A R T I C L E S
Wu et al.
MsCl (160 mg, 1.40 mmol) was added dropwise over 10 min
into a solution of 7a (567 mg, 1.4 mmol) and Et3N (1 mL, 7.0
mmol) in CH2Cl2 (7 mL) at 0 °C. The reaction mixture was warmed
to room temperature and stirred overnight and quenched with H2O
(7 mL). Usual workup gave 1a as a colorless oil (389 mg, 1.0 mmol,
72%). [R]D20 -36.0 (c 0.56, CHCl3); IR (KBr, cm-1): 2960, 2873,
7.15-7.21 (m, 1H), 7.35-7.41 (m, 1H), 7.51-7.54 (m, 1H),
7.61-7.64 (m, 1H); MS (EI) m/z (%): 328 (M + 1+, 100).
Preparation of (S)-2-(2-Bromophenyl)-N-(1-hydroxy-3,3-di-
methylbutan-2-yl)-2-methylpropanamide (9b). 9b was prepared
as a white solid (93%) using the same procedure as that for 9a.
Mp: 105-107 °C; IR (KBr, cm-1): 3370, 2958, 2866, 1651, 1504,
1437, 767, 757; 1H NMR (300 MHz, CDCl3): δ 0.82 (s, 9H),
1.69-1.71 (m, 6H), 2.98-3.02 (m, 1H), 3.50-3.57 (m, 1H),
3.68-3.74 (m, 1H), 3.79-3.87 (m, 1H), 7.16-7.22 (m, 1H),
7.37-7.42 (m, 1H), 7.53-7.56 (m, 1H), 7.62-7.65 (m, 1H); 13C
NMR (75 MHz, CDCl3): δ 26.4, 26.8, 26.9, 33.4, 48.8, 60.4, 63.4,
124.0, 127.9, 128.1, 129.0, 135.0, 142.9, 177.8; MS (EI) m/z (%):
286 (M-tBu+, 21.81), 284 (M-tBu+, 23.53), 199 (95.81), 197
(100.00); Anal. Calcd for C16H24BrNO2: C, 56.15; H, 7.07; N, 4.09.
Found: C, 56.30; H, 6.85; N, 3.98.
Preparation of (S)-2-[2-(2-Bromophenyl)propan-2-yl]-4-iso-
propyl-4,5-dihydrooxazole (10a).23 To a solution of amide 9a
(1.140 g, 3.5 mmol) in MeCN (8 mL) were added PPh3 (2.911 g,
11.1 mmol), Et3N (2.33 mL, 16.7 mmol), and CCl4 (3.22 mL, 33.3
mmol). The reaction mixture was stirred overnight at room
temperature. After completion of the reaction (monitored by TLC),
water (10 mL) was added and the resulting mixture was extracted
with CH2Cl2 (10 mL × 3). The combined organic phase was dried
over Na2SO4. The solvent was removed under reduced pressure,
and the crude product was purified by flash chromatography on
silica gel (petroleum ether/ethyl acetate ) 10) to give 10a as a
colorless oil (1.020 g, 3.3 mmol, 94%). 1H NMR (300 MHz,
CDCl3): δ 0.88 (d, J ) 7.0 Hz, 3H), 0.97 (d, J ) 7.0 Hz,
3H), 1.71-1.72 (m, 6H), 1.80-1.93 (m, 1H), 3.93-4.01 (m, 2H),
4.18-4.27 (m, 1H), 7.07-7.12 (m, 1H), 7.27-7.33 (m, 1H),
7.42-7.46 (m, 1H), 7.55-7.58(m, 1H); 13C NMR (75 MHz,
CDCl3): δ 17.9, 19.1, 27.2, 27.7, 32.3, 42.4, 70.3, 72.0, 123.8, 127.3,
127.4, 128.2, 134.6, 143.6, 171.7.
1
1699, 1435, 745, 697; H NMR (300 MHz, CDCl3): δ 0.82 (d, J
) 6.6 Hz, 3H), 0.91 (d, J ) 6.6 Hz, 3H), 1.59-1.71 (m, 1H),
3.69-3.82 (m, 2H), 3.88-4.05 (m, 3H), 6.88-6.92 (m, 1H),
7.14-7.38 (m, 13H); 31P NMR (121 MHz, CDCl3): δ -14.44; 13
C
NMR (75 MHz, CDCl3): δ 17.9, 18.8, 32.2, 33.1 (d, JPC ) 23 Hz),
69.8, 71.8, 127.0, 128.26 (d, JPC ) 6.8 Hz), 128.32 (d, JPC ) 16.6
Hz), 128.9, 129.3 (d, JPC ) 4.6 Hz), 133.63 (d, JPC ) 20.0 Hz),
133.65 (d, JPC ) 19.4 Hz), 133.72, 136.1 (d, JPC ) 13.1 Hz), 136.2
(d, JPC ) 10.3 Hz), 140.0 (d, JPC ) 26.8 Hz), 165.1; MS (EI) m/z
(%): 387 (M+, 2.33), 344 (2.25), 316 (100). Anal. Calcd for
C25H26NOP: C, 77.50; H, 6.76; N, 3.62. Found: C, 77.38; H, 6.80;
N, 3.52.
Preparation of (S)-2-[2-(Diphenylphosphino)benzyl]-4-tert-
butyl-4,5-dihydrooxazole (1b). 1b was prepared as a white solid
(43%, two steps) using the same procedure as that for 1a. Mp:
20
49-51 °C; [R]D -37.2 (c 1.00, CHCl3); IR (KBr, cm-1): 2960,
1666, 1471, 1433, 744, 695; 1H NMR (300 MHz, CDCl3): δ 0.85
(s, 9H), 3.69-3.76 (m, 1H), 3.87-4.02 (m, 4H), 6.87-6.92 (m,
1H), 7.12-7.40 (m, 13H); 31P NMR (121 MHz, CDCl3): δ -14.36;
13C NMR (75 MHz, CDCl3): δ 25.5, 32.8 (d, JPC ) 24 Hz), 33.1,
68.2, 75.2, 126.8, 128.13 (d, JPC ) 6.9 Hz), 128.15 (d, JPC ) 6.8
Hz), 128.2 (d, JPC ) 17.2 Hz), 128.7, 129.0 (d, JPC ) 4.6 Hz),
133.48 (d, JPC ) 19.4 Hz), 133.52, 135.9 (d, JPC ) 13.2 Hz) 136.0
(d, JPC ) 10.3 Hz), 136.1 (d, JPC ) 10.3 Hz), 139.8 (d, JPC ) 26.4
Hz), 165.0 (d, JPC ) 1.2 Hz); MS (EI) m/z (%): 401 (M+, 6.86),
316 (100). Anal. Calcd for C26H28NOP: C, 77.78; H, 7.03; N, 3.49.
Found: C, 77.45; H, 7.05; N, 3.28.
Preparation of (S)-2-[2-(2-Bromophenyl)propan-2-yl]-4-tert-
butyl-4,5-dihydrooxazole (10b). 10b was prepared as an oil (99%)
using the same procedure as that for 10a. IR (KBr, cm-1): 2976,
2955, 2903, 2869, 1664, 1471, 756; 1H NMR (300 MHz, CDCl3):
δ 0.92 (s, 9H), 1.72-1.74 (m, 6H), 3.89-3.95 (m, 1H), 4.01-4.07
(m, 1H), 4.15-4.21 (m, 1H), 7.07-7.13 (m, 1H), 7.28-7.33 (m,
1H), 7.42-7.45 (d, J ) 8.1 Hz, 1H), 7.55-7.58 (d, J ) 8.1 Hz,
1H); 13C NMR (75 MHz, CDCl3): δ 26.0, 27.2, 28.0, 34.0, 42.5,
69.1, 75.6, 123.7, 127.3, 127.4, 128.2, 134.6, 143.7, 171.7; MS
(EI) m/z (%): 324 (M+, 0.52), 244 (100); 268 (30.85), 266 (32.06).
Anal. Calcd for C16H22BrNO: C, 59.27; H, 6.84; N, 4.32. Found:
C, 59.30; H, 6.89; N, 4.14.
Preparation of (S)-2-[2-(Diphenylphosphino)benzyl]-4-phe-
nyl-4,5-dihydrooxazole (1c). 1c was prepared as a white solid
(48%, two steps) using the same procedure as that for 1a. Mp:
109-111 °C; [R]D20 -43.0 (c 1.15, CHCl3); IR (KBr, cm-1): 1662,
1432, 989, 752, 745, 698; 1H NMR (300 MHz, CDCl3): δ
3.90-3.98 (m, 1H), 4.05 (dd, J ) 15.5, 24 Hz, 2H), 4.36-4.44
(m, 2H), 6.91-6.96 (m, 1H), 7.16-7.48 (m, 18H); 31P NMR (121
MHz, CDCl3): δ -14.44; 13C NMR (75 MHz, CDCl3): δ 33.2 (d,
JPC ) 22.9 Hz), 69.5, 74.6, 126.6, 127.27, 127.34, 128.36, 128.46,
128.6, 129.2, 129.8 (d, JPC ) 4.6 Hz), 133.6, 133.7, 133.89, 133.95,
136.18, 136.24, 136.30, 136.37, 136.44, 139.9 (d, JPC ) 26.3 Hz),
142.3, 166.8 (observed complexity due to P-C splitting; definitive
assignments have not yet been made); MS (ESI) m/z: 422 (M +
1+). Anal. Calcd for C28H24NOP: C, 79.79; H, 5.74; N, 3.32. Found:
C, 79.62; H, 5.74, N, 3.10.
Preparation of (S)-2-{2-[2-(Diphenylphosphino)phenyl]pro-
pan-2-yl}-4-iso-propyl-4,5-dihydrooxazole (2a). To a solution of
10a (997 mg, 3.2 mmol) in THF (15 mL) at -78 °C was added
n-BuLi (1.6 M in hexane, 2.3 mL, 3.7 mmol) dropwise over 5 min.
The reaction mixture was stirred for 1 h at that temperature, and
then PPh2Cl (0.67 mL, 3.7 mmol) was added dropwise over 5 min
to the solution at -78 °C. The reaction mixture was warmed to
room temperature, stirred overnight, and quenched with a saturated
NH4Cl solution (15 mL). The water phase was extracted with Et2O
(15 mL × 3). The combined organic phases were dried over
Na2SO4. Evaporation of the organic solvents gave a residue, which
was purified by flash chromatography on silica gel (petroleum ether/
ethyl acetate ) 10) to give 2a as a white solid (766 mg, 1.8 mmol,
Preparation of (S)-2-(2-Bromophenyl)-N-(1-hydroxy-3-me-
thylbutan-2-yl)-2-methylpropanamide (9a).23 2-(2-Bromophenyl)-
2-methylpropanoic acid 8 (983 mg, 4.0 mmol) was added to thionyl
chloride (8 mL). The reaction mixture was refluxed for 3 h, and
the excess SOCl2 was removed in vacuo. Dry CH2Cl2 (2 mL) was
then added, and the mixture was concentrated in vacuo to remove
any remaining SOCl2 and this was repeated three times. Dry CH2Cl2
(8 mL) was then added to the acid chloride. Under an argon
atmosphere, L-valinol (500 mg, 4.8 mmol) and Et3N (0.9 mL, 6.4
mmol) were dissolved in dry CH2Cl2 (8 mL) and cooled to 0 °C.
The above acyl chloride solution was added dropwise over a period
of 0.5 h. The reaction mixture was allowed to warm up to room
temperature and stirred overnight. The resulting solution was
washed with water (10 mL) and dried over Na2SO4. The solvent
was removed under reduced pressure, and the crude product was
purified by flash chromatography on silica gel (petroleum ether/
ethyl acetate ) 2) to give 9a as an oil (1.140 g, 3.5 mmol,
87%). 1H NMR (300 MHz, CDCl3): δ 0.79 (d, J ) 6.6 Hz,
3H), 0.87 (d, J ) 6.6 Hz, 3H), 1.62-1.72 (m, 6H), 1.72-1.82 (m,
1H), 2.76-2.80 (m, 1H), 3.58-3.79 (m, 3H), 5.25-5.27 (br d, 1H),
20
57%). Mp: 95-97 °C; [R]D -48.5 (c 0.935, CHCl3); IR (KBr,
cm-1): 3051, 2982, 2953, 2873, 1652, 1478, 747, 737, 695; 1H
NMR (300 MHz, CDCl3): δ 0.76 (d, J ) 7.0 Hz, 3H), 0.84 (d, J
) 7.0 Hz, 3H), 1.73-1.79 (m, 1H), 1.77 (s, 3H), 1.84 (s, 3H),
3.60-3.70 (m, 3H), 7.15-7.40 (m, 13H), 7.51-7.55 (m, 1H); 13
C
NMR (75 MHz, CDCl3): δ 17.4, 19.1, 29.9 (d, JPC ) 5.7 Hz), 30.1
(d, JPC ) 7.4 Hz), 31.8, 42.2 (d, JPC ) 6.9 Hz), 69.4, 71.8, 125.4,
125.5, 126.8, 127.9, 128.0, 128.1, 128.17, 128.24, 129.6, 133.1 (d,
JPC ) 18.9 Hz), 135.6, 135.9, 138.2, 138.3, 138.40, 138.44, 151.4,
(d, JPC ) 26 Hz), 173.0 (observed complexity due to P-C splitting;
definitive assignments have not yet been made); 31P NMR (121
9
9724 J. AM. CHEM. SOC. VOL. 130, NO. 30, 2008